Physician

Julien Beattie-Lanoue, MD

According to 2025 Medicare claims, Julien Beattie-Lanoue, MD (NPI: 1407218308) practices micrographic dermatologic surgery in the Tampa, FL market, with the plurality of this provider's patient population coming from Hillsborough, FL. This provider's primary affiliated billing organization is LEAVITT MEDICAL ASSOCIATES OF FLORIDA INC (NPI: 1528097284; TIN: 593549147) and primary practice location at 33613-5424. Beattie-Lanoue is affiliated with the Rancho Health Management, LLC (ACO ID: D0015), participating under the REACH model.

Beattie-Lanoue's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 429 traditional Medicare patients, billed 1,912 HCPCS/CPT codes, and received $1,845,168 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 477 prescription claims across 279 beneficiaries totaling $12,821 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). Open Payments data shows 4 records totaling $153. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $2,369 and ending at $12,821. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$923K$1.8M2021 Medicare payment: $40,070 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $236,465 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $311,584 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,845,168 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202145123$40,070
2022282740$236,465
2023420975$311,584
20244291,912$1,845,168

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$6.5K$13K2016 Drug cost: $2,369 (USD; Tot_Drug_Cst)2017 Drug cost: $9,465 (USD; Tot_Drug_Cst)2018 Drug cost: $12,941 (USD; Tot_Drug_Cst)2019 Drug cost: $1,981 (USD; Tot_Drug_Cst)2020 Drug cost: $2,981 (USD; Tot_Drug_Cst)2021 Drug cost: $2,269 (USD; Tot_Drug_Cst)2022 Drug cost: $2,406 (USD; Tot_Drug_Cst)2023 Drug cost: $8,179 (USD; Tot_Drug_Cst)2024 Drug cost: $12,821 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20161734$2,369
20171865$9,465
2018N/R13$12,941
20192540$1,981
202087120$2,981
20216997$2,269
2022108129$2,406
2023188281$8,179
2024279477$12,821

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks317415$503
17313Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks7997$473
17312Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks111146$312
17000Destruction of precancer skin growth, 1 growth5462$26
17003Destruction of precancer skin growth, 2-14 growths31102$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Clobetasol PropionateClobetasol Propionate19630$3,852
FluorouracilFluorouracil28763$2,651
TretinoinTretinoin12375$1,341
Doxycycline MonohydrateDoxycycline Monohydrate38682$926
Doxycycline HyclateDoxycycline Hyclate117819$798

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$153Kerecis Limited
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Julien Beattie-Lanoue, MD?

Tedicare shows public-source Medicare data for Julien Beattie-Lanoue, MD (NPI 1407218308), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Julien Beattie-Lanoue, MD have ACO affiliation data?

Julien Beattie-Lanoue, MD is shown with ACO affiliation data for Rancho Health Management, LLC (REACH, ACO ID D0015).

What billing organization is linked to Julien Beattie-Lanoue, MD?

Julien Beattie-Lanoue, MD is linked to LEAVITT MEDICAL ASSOCIATES OF FLORIDA INC (billing NPI 1528097284) in the available physician profile data.

Does Julien Beattie-Lanoue, MD have Open Payments data?

Julien Beattie-Lanoue, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.